SciELO - Scientific Electronic Library Online

 
vol.37 número1Síndrome de Austrian en endocarditis infecciosa: reporte de un caso y manejo médico quirúrgico exitosoCompromiso de conciencia y bradicardia índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Revista chilena de cardiología

versión On-line ISSN 0718-8560

Resumen

ALEMAN, Larissa; RAMIREZ-SAGREDO, Andrea; ORTIZ-QUINTERO, Jafet  y  LAVANDERO, Sergio. Type II Diabetes and Ischemic Heart disease: pathophysiology, gen regulation and future therapeutic options. Rev Chil Cardiol [online]. 2018, vol.37, n.1, pp.42-54. ISSN 0718-8560.  http://dx.doi.org/10.4067/S0718-85602018000100042.

In recent years, type 2 diabetes mellitus has evolved as a rapidly increasing epidemic and affects millions of people worldwide. Ischemic heart disease (IHD) is the main cause of death among diabetic patients, who have a higher cardiovascular risk than non-diabetics. Both, DM2 and IHD are characterized by being preventable, however there are several common risk factors that contribute to their development.

The mechanisms that explain accelerated atherosclerosis and increased risk of cardiovascular diseases in patients with type 2 diabetes mellitus include damage by hyperglycemia, dyslipidemia and inflammation on vascular endothelium.

Diabetes is the result of a complex interaction between genetics and the environment, recently, several genes have been identified that appear to be involved in diabetes and ischemic heart disease that could explain its relationship and serve as new therapeutic possibilities.

In this article, we review the relationship between diabetes and ischemic heart disease, the molecular mechanisms and the discovery of genetic risk factors common to both diseases and their implication in the development of new therapeutic targets.

Palabras clave : Diabetes; ischemic heart disease; genetics.

        · resumen en Español     · texto en Español     · Español ( pdf )